US Patent 11434485 Synthetic transfer RNA with extended anticodon loop
Patent 11434485 was granted and assigned to Arcturus Therapeutics on September, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114344850
Date of Patent
September 6, 2022
0Patent Application Number
169809270
Date Filed
March 14, 2019
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114344850
Date of Patent
September 6, 2022
0Patent Application Number
169809270
Date Filed
March 14, 2019
0Patent Primary Examiner
Edits on 7 Sep, 2022
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+519 characters)
US Patent 11434485 Synthetic transfer RNA with extended anticodon loop
Article
A synthetic transfer RNA with an extended anticodon loop. A synthetic suppressor transfer RNA useful for the treatment of a genetic disease like cystic fibrosis associated with a nonsense mutation. The synthetic transfer RNA contains an extended anticodon loop with two consecutive anticodon base triplets configured to base-pair to two consecutive codon base triplets on an mRNA. The first anticodon base triplet or the second anticodon base triplet is configured to base-pair to a stop codon base triplet on the mRNA.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11434485
Date of Patent
September 6, 2022
Patent Application Number
16980927
Date Filed
March 14, 2019
Patent Primary Examiner
Find more entities like US Patent 11434485 Synthetic transfer RNA with extended anticodon loop
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
